Effects of PF-06412562 on Value-based Decision-making in Healthy Individuals: a Mono-center, Randomized, Placebo Controlled, Double-blind Study (Phase I)
Latest Information Update: 05 Nov 2021
At a glance
- Drugs PF 6412562 (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
Most Recent Events
- 03 Nov 2020 Status changed from recruiting to completed.
- 14 Jun 2017 New trial record